In addition to suppressing appetite, boosting insulin secretion and slowing stomach emptying, these drugs appear to influence brain pathways involved in food reward and cravings, making them a potential candidate for tackling the loss of control that characterizes binge eating
The index date for this group was defined as the first date any of these GLP-1 medications were prescribed
Wegovy is administered at a higher dose of semaglutide compared to Ozempic, with the maximum dose of Wegovy being 2.4 mg per week, while Ozempics maximum dose is 1.0 mg per week
As a result, your appetite decreases, and you put the fork down
Hou Y, Moreau F, Chadee K (2012) PPAR is an E3 ligase that induces the degradation of NFB/p65
Perhaps a combination of these effects help the body to have less hunger signaling and potential weight loss